Table 3.
Distribution of HIV-1 subtypes according to age, gender, and race
| HIV-1 subtypes | P value | ||||||
|---|---|---|---|---|---|---|---|
| CRF01_AE | CRF08_BC | CRF07_BC | B | C | URFs | ||
| Age (years) | 0·189 | ||||||
| 1–18 | 3 (27·3%) | 4 (36·4%) | 1 (9·1%) | 0 (0·0%) | 0 (0·0%) | 3 (27·3%) | |
| 19–25 | 11 (16·9%) | 26 (40·0%) | 14 (21·5%) | 2 (3·1%) | 6 (9·2%) | 6 (9·2%) | |
| 26–35 | 21 (17·4%) | 58 (47·9%) | 25 (20·7%) | 3 (2·5%) | 5 (4·1%) | 9 (7·4%) | |
| 36–45 | 14 (23·0%) | 30 (49·2%) | 13 (21·3%) | 3 (4·9%) | 0 (0·0%) | 1 (1·6%) | |
| ⩾ 46 | 8 (25·0%) | 11 (34·4%) | 8 (25·0%) | 0 (0·0%) | 0 (0·0%) | 5 (15·6%) | |
| Gender | 0·817 | ||||||
| Female (n = 112) | 21 (18·8%) | 48 (42·9%) | 24 (21·4%) | 5 (4·5%) | 4 (3·6%) | 10 (8·9%) | |
| Male (n = 178) | 36 (20·2%) | 81 (45·5%) | 37 (20·8%) | 3 (1·7%) | 7 (3·9%) | 14 (7·9%) | |
| Ethnic group | <0·001* | ||||||
| Han (n = 200) | 37 (18·5%) | 87 (43·5%) | 50 (25·0%) | 4 (2·0%) | 6 (3·0%) | 16 (8·0%) | |
| Dai (n = 17) | 8 (47·1%) | 1 (5·9%) | 2 (11·8%) | 3 (17·6%)† | 1 (5·9%) | 2 (11·8%) | |
| Hui (n = 16) | 1 (6·3%) | 12 (75·0%)‡ | 3 (18·8%) | 0 | 0 | 0 | |
| Yi (n = 14) | 1 (7·1%) | 9 (64·3%)‡ | 4 (28·6%) | 0 | 0 | 0 | |
| Bai (n = 11) | 2 (18·2%) | 7 (63·6%)‡ | 1 (9·1%) | 1 (9·1%) | 0 | 0 | |
| Zhuang (n = 8) | 3 (37·5%) | 3 (37·5%) | 0 | 0 | 0 | 2 (25·0%) | |
| Jingpo (n = 7) | 1 (14·3%) | 0 (0·0%) | 1 (14·3%) | 0 | 3 (42·9%)† | 2 (28·6%) | |
| Hani (n = 5) | 1 (20·0%) | 4 (80·0%)‡ | 0 (0·0%) | 0 | 0 | 0 | |
| Other§ (n = 12) | 3 (25·0%) | 6 (50·0%) | 0 | 0 | 1 (8·3%) | 2 (16·7%) | |
*
Significant association by Fisher's exact test.
†
Significant difference in the corresponding proportion compared to Han.
‡
Significant difference in the corresponding proportion compared to Dai.
§
The 12 patients classified as ‘other’ include two each of Yao, Wa, Naxi, and Miao groups, and one each of Du, Lisu, and Lahu groups, and one whose race was unknown.